In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability

Monte Willis, Lynell W. Klassen, Dean J. Tuma, Michael F. Sorrell, Geoffrey M. Thiele

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Circulating antibodies against malondialdehyde-acetaldehyde (MAA) haptenated proteins are increased significantly in patients with alcohol-induced cirrhosis and hepatitis and are associated with severity of liver damage. Additionally, MAA haptenated proteins are highly immunogenic without the use of adjuvant and have been suggested to induce autoreactive responses. The mechanism of this immunogenicity is currently unknown but may be mediated by cell death in a similar manner as other autoimmune diseases such as systemic lupus erythematosus, mixed connective tissue disease, myositis, and Sjögren's disease. Methods: Antigen-presenting cells, lymphocytes, and hepatocytes were exposed to different levels of MAA haptenated hen egg lysozyme and assessed by [ 3 H]thymidine incorporation and (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) conversion for viability. Results: The cells investigated in this study were those that potentially may be involved in the development of autoimmune liver damage; they include antigen-presenting cells, lymphocytes, and cells of the liver itself. Each cell type was found to be sensitive to MAA haptenated protein-induced cell death at levels between 690 μM (10 μg/ml) and 6.9 mM (100 μg/ml), which may be found locally after chronic ethanol consumption. Antigen-presenting cells (macrophage and B cells) were found to be activated at concentrations just under those levels associated with cell death. Conclusions: A dose response to MAA haptenated protein-induced cell death is seen in antigen-presenting cells, lymphocytes, and hepatocytes in vitro. Recent reports have associated both apoptotic and necrotic cell death with the development of autoimmune disease; thus, it is possible that this may be one mechanism by which in vivo immunogenicity is mediated by aldehyde haptenated proteins.

Original languageEnglish (US)
Pages (from-to)158-164
Number of pages7
JournalAlcoholism: Clinical and Experimental Research
Volume26
Issue number2
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Acetaldehyde
Cell proliferation
Cell death
Malondialdehyde
Antigen-Presenting Cells
Cell Survival
Cell Death
Cell Proliferation
Lymphocytes
Liver
Proteins
Autoimmune Diseases
Hepatocytes
Mixed Connective Tissue Disease
Myositis
Macrophages
Aldehydes
Systemic Lupus Erythematosus
Thymidine
Hepatitis

Keywords

  • Aldehydes
  • Cell Death
  • Hapten
  • Immune System
  • Liver

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health

Cite this

In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability. / Willis, Monte; Klassen, Lynell W.; Tuma, Dean J.; Sorrell, Michael F.; Thiele, Geoffrey M.

In: Alcoholism: Clinical and Experimental Research, Vol. 26, No. 2, 01.01.2002, p. 158-164.

Research output: Contribution to journalArticle

Willis, Monte ; Klassen, Lynell W. ; Tuma, Dean J. ; Sorrell, Michael F. ; Thiele, Geoffrey M. / In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability. In: Alcoholism: Clinical and Experimental Research. 2002 ; Vol. 26, No. 2. pp. 158-164.
@article{76ebeeaae2d34e699aab645ac34ed875,
title = "In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability",
abstract = "Background: Circulating antibodies against malondialdehyde-acetaldehyde (MAA) haptenated proteins are increased significantly in patients with alcohol-induced cirrhosis and hepatitis and are associated with severity of liver damage. Additionally, MAA haptenated proteins are highly immunogenic without the use of adjuvant and have been suggested to induce autoreactive responses. The mechanism of this immunogenicity is currently unknown but may be mediated by cell death in a similar manner as other autoimmune diseases such as systemic lupus erythematosus, mixed connective tissue disease, myositis, and Sj{\"o}gren's disease. Methods: Antigen-presenting cells, lymphocytes, and hepatocytes were exposed to different levels of MAA haptenated hen egg lysozyme and assessed by [ 3 H]thymidine incorporation and (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) conversion for viability. Results: The cells investigated in this study were those that potentially may be involved in the development of autoimmune liver damage; they include antigen-presenting cells, lymphocytes, and cells of the liver itself. Each cell type was found to be sensitive to MAA haptenated protein-induced cell death at levels between 690 μM (10 μg/ml) and 6.9 mM (100 μg/ml), which may be found locally after chronic ethanol consumption. Antigen-presenting cells (macrophage and B cells) were found to be activated at concentrations just under those levels associated with cell death. Conclusions: A dose response to MAA haptenated protein-induced cell death is seen in antigen-presenting cells, lymphocytes, and hepatocytes in vitro. Recent reports have associated both apoptotic and necrotic cell death with the development of autoimmune disease; thus, it is possible that this may be one mechanism by which in vivo immunogenicity is mediated by aldehyde haptenated proteins.",
keywords = "Aldehydes, Cell Death, Hapten, Immune System, Liver",
author = "Monte Willis and Klassen, {Lynell W.} and Tuma, {Dean J.} and Sorrell, {Michael F.} and Thiele, {Geoffrey M.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1111/j.1530-0277.2002.tb02520.x",
language = "English (US)",
volume = "26",
pages = "158--164",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability

AU - Willis, Monte

AU - Klassen, Lynell W.

AU - Tuma, Dean J.

AU - Sorrell, Michael F.

AU - Thiele, Geoffrey M.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background: Circulating antibodies against malondialdehyde-acetaldehyde (MAA) haptenated proteins are increased significantly in patients with alcohol-induced cirrhosis and hepatitis and are associated with severity of liver damage. Additionally, MAA haptenated proteins are highly immunogenic without the use of adjuvant and have been suggested to induce autoreactive responses. The mechanism of this immunogenicity is currently unknown but may be mediated by cell death in a similar manner as other autoimmune diseases such as systemic lupus erythematosus, mixed connective tissue disease, myositis, and Sjögren's disease. Methods: Antigen-presenting cells, lymphocytes, and hepatocytes were exposed to different levels of MAA haptenated hen egg lysozyme and assessed by [ 3 H]thymidine incorporation and (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) conversion for viability. Results: The cells investigated in this study were those that potentially may be involved in the development of autoimmune liver damage; they include antigen-presenting cells, lymphocytes, and cells of the liver itself. Each cell type was found to be sensitive to MAA haptenated protein-induced cell death at levels between 690 μM (10 μg/ml) and 6.9 mM (100 μg/ml), which may be found locally after chronic ethanol consumption. Antigen-presenting cells (macrophage and B cells) were found to be activated at concentrations just under those levels associated with cell death. Conclusions: A dose response to MAA haptenated protein-induced cell death is seen in antigen-presenting cells, lymphocytes, and hepatocytes in vitro. Recent reports have associated both apoptotic and necrotic cell death with the development of autoimmune disease; thus, it is possible that this may be one mechanism by which in vivo immunogenicity is mediated by aldehyde haptenated proteins.

AB - Background: Circulating antibodies against malondialdehyde-acetaldehyde (MAA) haptenated proteins are increased significantly in patients with alcohol-induced cirrhosis and hepatitis and are associated with severity of liver damage. Additionally, MAA haptenated proteins are highly immunogenic without the use of adjuvant and have been suggested to induce autoreactive responses. The mechanism of this immunogenicity is currently unknown but may be mediated by cell death in a similar manner as other autoimmune diseases such as systemic lupus erythematosus, mixed connective tissue disease, myositis, and Sjögren's disease. Methods: Antigen-presenting cells, lymphocytes, and hepatocytes were exposed to different levels of MAA haptenated hen egg lysozyme and assessed by [ 3 H]thymidine incorporation and (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) conversion for viability. Results: The cells investigated in this study were those that potentially may be involved in the development of autoimmune liver damage; they include antigen-presenting cells, lymphocytes, and cells of the liver itself. Each cell type was found to be sensitive to MAA haptenated protein-induced cell death at levels between 690 μM (10 μg/ml) and 6.9 mM (100 μg/ml), which may be found locally after chronic ethanol consumption. Antigen-presenting cells (macrophage and B cells) were found to be activated at concentrations just under those levels associated with cell death. Conclusions: A dose response to MAA haptenated protein-induced cell death is seen in antigen-presenting cells, lymphocytes, and hepatocytes in vitro. Recent reports have associated both apoptotic and necrotic cell death with the development of autoimmune disease; thus, it is possible that this may be one mechanism by which in vivo immunogenicity is mediated by aldehyde haptenated proteins.

KW - Aldehydes

KW - Cell Death

KW - Hapten

KW - Immune System

KW - Liver

UR - http://www.scopus.com/inward/record.url?scp=0036168647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036168647&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.2002.tb02520.x

DO - 10.1111/j.1530-0277.2002.tb02520.x

M3 - Article

C2 - 11964554

AN - SCOPUS:0036168647

VL - 26

SP - 158

EP - 164

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 2

ER -